Global Alzheimer’s Disease Drugs Market

1
(No Transcript)
2
Table of Contents

• Executive Summary
• 2. Global Alzheimers Disease - Drugs Market and
  Prevalence Analysis
• 2.1 Global Alzheimers Disease - Drugs Market and
  Forecast (2010 - 2020)
• 2.2 Global Alzheimers Disease - Prevalence and
  Forecast (2010 - 2020)
• 3. Global Alzheimers Disease - Country Wise
  Market Share and Forecast (2013 - 2020)

3
4. Global Alzheimers Disease - Drugs Sales and
Forecast To 2020
4.1 Exelon (Rivastigmine) Sales and Forecast 4.2
Razadyne/Reminyl Sales and Forecast 4.3 Memary
(Memantine) Sales and Forecast 4.4 Ebixa
(Memantine) Sales and Forecast 4.5 Aricept
(Donepezil) Sales and Forecast 4.6 Rivastach
Sales and Forecast 4.7 Namenda (Memantine) Sales
and Forecast 4.8 Nootropil (Piracetam) Sales and
Forecast 4.9 Namzaric (Memantine and Donepezil)
Sales and Forecast
4
5. Global Alzheimers Disease - Pipeline Drugs
Analysis and Sales Forecast
5.1 Solanezumab Drugs Analysis and Sales
Forecast 5.1.1 About Solanezumab 5.1.2 Clinical
Trials 5.1.3 Solanezumab Drugs Sales
Forecast 5.2 ABT-126 Drugs Analysis and Sales
Forecast 5.2.1 About ABT-126 5.2.2 Clinical
Trials 5.2.3 ABT-126 Drugs Sales Forecast
5
Continue (www.igateresearch.com)
5.3 Idalopirdine Drugs Analysis and Sales
Forecast 5.3.1 About Idalopirdine 5.3.2 Clinical
Trials 5.3.3 Idalopirdine Drugs Sales
Forecast 5.4 Gantenerumab Drugs Analysis and
Sales Forecast 5.4.1 About Gantenerumab 5.4.2 Cli
nical Trials 5.4.3 Gantenerumab Drugs Sales
Forecast
6
Continue (www.igateresearch.com)
5.5 Crenezumab Drugs Analysis and Sales
Forecast 5.5.1 About Crenezumab 5.5.2 Clinical
Trials 5.5.3 Crenezumab Drugs Sales
Forecast 5.6 Lu AE58054 Drugs Analysis and Sales
Forecast 5.6.1 About Lu AE58054 5.6.2 Clinical
Trials 5.6.3 Lu AE58054 Drugs Sales
Forecast 5.7 BIIB037 Drugs Analysis and Sales
Forecast 5.7.1 About BIIB037 5.7.2 Clinical
Trials 5.7.3 BIIB037 Drugs Sales Forecast
7
6. Alzheimers Disease Drugs Market Prevalence
- Country Wise Analysis
6.1 United States - Alzheimers Disease Drugs
Market Prevalence Analysis 6.1.1 United States
- Alzheimers Disease Drugs Market Forecast
(2013 - 2020) 6.1.2 United States - Alzheimers
Disease Prevalence Forecast (2010 - 2020)
6.2 France - Alzheimers Disease Drugs Market
and Prevalence Analysis 6.2.1 France -
Alzheimers Disease Drugs Market and Forecast
(2013 - 2020) 6.2.2 France - Alzheimers Disease
Prevalence and Forecast (2012 - 2020) 6.3
Germany - Alzheimers Disease Drugs Market and
Prevalence Analysis 6.3.1 Germany - Alzheimers
Disease Drugs Market and Forecast (2013 - 2020)
6.3.2 Germany - Alzheimers Disease Prevalence
and Forecast (2012 - 2020)
8
Continue (www.igateresearch.com)
6.4 Italy - Alzheimers Disease Drugs Market and
Prevalence Analysis 6.4.1 Italy - Alzheimers
Disease Drugs Market and Forecast (2013 - 2020)
6.4.2 Italy - Alzheimers Disease Prevalence and
Forecast (2012 - 2020) 6.5 Spain -
Alzheimers Disease Drugs Market Prevalence
Analysis 6.5.1 Spain - Alzheimers Disease
Drugs Market Forecast (2013 - 2020) 6.5.2
Spain - Alzheimers Disease Prevalence Forecast
(2012 - 2020) 6.6 United Kingdom - Alzheimers
Disease Drugs Market Prevalence Analysis 6.6.1
United Kingdom - Alzheimers Disease Drugs Market
Forecast (2013 - 2020) 6.6.2 United Kingdom -
Alzheimers Disease Prevalence Forecast (2012 -
2020)
9
Continue (www.igateresearch.com)
6.7 Japan - Alzheimers Disease Drugs Market
Prevalence Analysis 6.7.1 Japan - Alzheimers
Disease Drugs Market Forecast (2013 - 2020)
6.7.2 Japan - Alzheimers Disease Prevalence
Forecast (2012 - 2020) 6.8 China - Alzheimers
Disease Drugs Market Prevalence
Analysis 6.8.1 China - Alzheimers Disease Drugs
Market Forecast (2013 - 2020) 6.8.2 China -
Alzheimers Disease Prevalence Forecast (2010 -
2020) 6.9 India - Alzheimers Disease Drugs
Market Prevalence Analysis 6.9.1 India -
Alzheimers Disease Drugs Market Forecast (2013
- 2020) 6.9.2 India - Alzheimers Disease
Prevalence Forecast (2010 - 2020)
10
7. Global Alzheimers Disease Drugs Market -
Major Deals Analysis
7.1 Global Alzheimers Disease Drugs Market -
Strategic Alliance 7.2 Global Alzheimers Disease
Drugs Market - Licensing Agreement 7.3 Global
Alzheimers Disease Drugs Market - Collaboration
Deals 7.4 Global Alzheimers Disease Drugs Market
- Mergers and Acquisitions 8. Global Alzheimers
Disease Drugs Research - Funding Analysis 8.1
National Institute of Health (2011 - 2016) 8.2
Alzheimer's Association (2011 - 2014) 8.3 Cure
Alzheimers Fund (2008 - 2014) 8.4 Alzheimers
Drug Discovery Foundation (2008 - 2013) 8.5
BrightFocus Foundation (2010 - 2014)
11
9. Global Alzheimers Disease Drug Market -
Driving Factors
9.1 Growing Aging Population 9.1.1 Global Ageing
Indicators 9.1.2 Population Aged 60 or Over
World and Development Regions, 1950 - 2050 9.1.3
Worldwide - Distribution of Population Aged 60
Years or Over By Broad Age Group, 1950
2050 9.2 Unmet Medical Needs 9.3 Strong Pipeline
Candidate Expected to Drive Alzheimers Disease
Drugs Market 9.4 Future Drugs for Disease
Modification in Alzheimers Disease
12
10. Global Alzheimers Disease Drug Market -
Challenges
10.1 Lack of Validated Targets Lack of Animal
Models 10.2 Barriers in the Design and
Implementation of Clinical Trials 10.3 Barriers
in Academia Regulatory Issues 10.4 Alzheimers
Drug Failure Insinuation for Future RD in
Neuroscience 10.5 Costly Alzheimers Drug
Development Dissuade Drug Companies 10.6 Research
Setbacks and Stepping Stones 10.7 Country Wise
Barriers to Growth for Alzheimers Disease Drugs
Market 10.7.1 Unite States 10.7.2 France 10.7.3
Germany 10.7.4 United Kingdom 10.7.5 Japan 10.7.6
China 10.7.7 India
13
Source of Information
iGATE RESEARCH employs rigorous primary and
secondary research techniques in developing
distinctive data sets and research material for
business reports. This report is built by using
data and information sourced from Proprietary
Information Database, Primary and Secondary
Research Methodologies, and In house analysis by
iGATE Research dedicated team of qualified
professionals with deep industry experience and
expertise.
14
Published By
iGATE RESEARCH Phone [phone]
(India) 91-706-527-9335 (India)
Email info_at_igateresearch.com Internet
www.igateresearch.com          
15
Format
Report Title Global Alzheimers Disease Drugs
Market and Pipeline Drugs Market Analysis to
2020 To Order the Report Visit
http//www.igateresearch.com/ProductDetail.php?p
d_nameGlobal20Alzheimers20Disease20Drugs20Mar
ket20Analysis
Single User License US 1,100
Hard-copy Mail Delivery US 1,250
CD-ROM Mail Delivery US 1,200
Multi User License US 1,600

16
Order the Report
iGATE RESEARCH PVT. LTD. Web www.igateresearch.c
om To order the Report E-Mail 
info_at_igateresearch.com Contact No.
91-858-684-0791, 91-706-527-9335 (INDIA) For
Report Related Query E-Mail 
info_at_igateresearch.com Contact No.
91-858-684-0791, 91-706-527-9335 (INDIA)